Dr. Mock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 984-974-1000
Education & Training
- Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2014
- Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
- University of Texas Southwestern Medical SchoolClass of 2007
Certifications & Licensure
- NC State Medical License 2014 - 2025
- MD State Medical License 2010 - 2015
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia Start of enrollment: 2020 Sep 29
Publications & Presentations
PubMed
- 76 citationsRegulatory T cell DNA methyltransferase inhibition accelerates resolution of lung inflammationBenjamin D. Singer, Jason R. Mock, Neil R. Aggarwal, Brian T. Garibaldi, Venkataramana K. Sidhaye
American Journal of Respiratory Cell and Molecular Biology. 2015-05-01 - 59 citationsSARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice.Kenneth H Dinnon 3rd, Sarah R Leist, Kenichi Okuda, Hong Dang, Ethan J Fritch
Science Translational Medicine. 2022-09-28 - 14 citationsA model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies.Kenneth H Dinnon 3rd, Sarah R Leist, Kenichi Okuda, Hong Dang, Ethan J Fritch
Biorxiv. 2022-02-15
Press Mentions
- Newsworthy from the School of Medicine, Week of March 4 – 10March 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: